ExpressionEdits News!

14/10/2024

Expression Edits have been named in Labiotech as one of 10 start-ups to watch in 2024. Headquartered right here on Campus, ExpressionEdits has created its Genetic Syntax Engine, a computational platform that is said to “perfect genetic grammar.” What this means is that with the help of AI, it can redesign transgenes to unlock protein expression across different therapeutic fields. 

Earlier this year, ExpressionEdits bagged $13 million in a seed funding round, the money will drive candidate selection for preclinical studies and the development of a pipeline of recombinant protein-based medicines. 

Catch up with all ten companies in the article HERE